WuXi Biologics (Cayman) Management
Management criteria checks 1/4
WuXi Biologics (Cayman)'s CEO is Chris Chen, appointed in Jan 2016, has a tenure of 8.42 years. total yearly compensation is CN¥96.91M, comprised of 4.1% salary and 95.9% bonuses, including company stock and options. directly owns 0.34% of the company’s shares, worth €20.29M. The average tenure of the management team and the board of directors is 1.8 years and 6.8 years respectively.
Key information
Chris Chen
Chief executive officer
CN¥96.9m
Total compensation
CEO salary percentage | 4.1% |
CEO tenure | 8.4yrs |
CEO ownership | 0.3% |
Management average tenure | 1.8yrs |
Board average tenure | 6.8yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2023 | CN¥97m | CN¥4m | CN¥3b |
Sep 30 2023 | n/a | n/a | CN¥4b |
Jun 30 2023 | n/a | n/a | CN¥4b |
Mar 31 2023 | n/a | n/a | CN¥4b |
Dec 31 2022 | CN¥79m | CN¥3m | CN¥4b |
Sep 30 2022 | n/a | n/a | CN¥4b |
Jun 30 2022 | n/a | n/a | CN¥4b |
Mar 31 2022 | n/a | n/a | CN¥4b |
Dec 31 2021 | CN¥51m | CN¥3m | CN¥3b |
Sep 30 2021 | n/a | n/a | CN¥3b |
Jun 30 2021 | n/a | n/a | CN¥3b |
Mar 31 2021 | n/a | n/a | CN¥2b |
Dec 31 2020 | CN¥31m | CN¥3m | CN¥2b |
Sep 30 2020 | n/a | n/a | CN¥1b |
Jun 30 2020 | n/a | n/a | CN¥1b |
Mar 31 2020 | n/a | n/a | CN¥1b |
Dec 31 2019 | CN¥25m | CN¥3m | CN¥1b |
Sep 30 2019 | n/a | n/a | CN¥922m |
Jun 30 2019 | n/a | n/a | CN¥831m |
Mar 31 2019 | n/a | n/a | CN¥731m |
Dec 31 2018 | CN¥20m | CN¥2m | CN¥631m |
Sep 30 2018 | n/a | n/a | CN¥520m |
Jun 30 2018 | n/a | n/a | CN¥410m |
Mar 31 2018 | n/a | n/a | CN¥331m |
Dec 31 2017 | CN¥24m | CN¥2m | CN¥253m |
Compensation vs Market: Chris's total compensation ($USD13.34M) is above average for companies of similar size in the German market ($USD3.35M).
Compensation vs Earnings: Chris's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
CEO
Chris Chen (51 yo)
8.4yrs
Tenure
CN¥96,911,000
Compensation
Dr. Zhisheng Chen, also known as Chris, Ph.D. has been the Chief Executive Officer & Executive Director at WuXi Biologics (Cayman) Inc. since January 01, 2016 and since February 27, 2014 respectively. Dr....
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Founder & Chairman | 10.3yrs | no data | no data | |
CEO & Executive Director | 8.4yrs | CN¥96.91m | 0.34% CN¥ 20.3m | |
Honorary President of Global Biologics Development | 9.2yrs | CN¥32.89m | 0.012% CN¥ 688.0k | |
CFO & Executive VP | 2.6yrs | no data | no data | |
COO & Senior VP | less than a year | no data | no data | |
Chief Technology Officer and Executive VP of Global Biologics Development Department | less than a year | no data | no data | |
Chief Scientific Officer & President of Global Biologics Research | no data | no data | no data | |
Senior VP & Head of Investor Relations | less than a year | no data | no data | |
VP & Head of Legal Department | no data | no data | no data | |
Chief Compliance Officer | 1.8yrs | no data | no data | |
VP & Head of Global Human Resources | no data | no data | no data | |
Senior VP and Head of Global BD & Alliance Management | no data | no data | no data |
1.8yrs
Average Tenure
56yo
Average Age
Experienced Management: 1FW2's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Founder & Chairman | 10.3yrs | no data | no data | |
CEO & Executive Director | 10.3yrs | CN¥96.91m | 0.34% CN¥ 20.3m | |
Honorary President of Global Biologics Development | 8.1yrs | CN¥32.89m | 0.012% CN¥ 688.0k | |
Independent Non-Executive Director | 1.1yrs | CN¥710.00k | 0.00062% CN¥ 36.6k | |
Member of Scientific Advisory Board | 6.4yrs | no data | no data | |
Member of Scientific Advisory Board | 6.4yrs | no data | no data | |
Member of Scientific Advisory Board | 6.4yrs | no data | no data | |
Member of Scientific Advisory Board | 6.4yrs | no data | no data | |
Independent Non-Executive Director | 7.1yrs | CN¥906.00k | 0.00053% CN¥ 31.3k | |
Non-Executive Director | 8.1yrs | no data | no data | |
Non-Executive Director | 8.1yrs | no data | no data | |
Independent Non-Executive Director | 4yrs | CN¥933.00k | 0.0049% CN¥ 289.1k |
6.8yrs
Average Tenure
59.5yo
Average Age
Experienced Board: 1FW2's board of directors are considered experienced (6.8 years average tenure).